- Home
- LUCY vs ICCM Comparison
LUCY vs ICCM Comparison
Compare LUCY & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LUCY | ICCM |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4M | 8.3M |
| IPO Year | 2021 | 2013 |
Fundamental Metrics
Financial Performance| Metric | LUCY | ICCM |
|---|---|---|
| Price | $0.84 | $1.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $22.67 |
| AVG Volume (30 Days) | 155.4K | ★ 166.3K |
| Earning Date | 11-12-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,661,669.00 | N/A |
| Revenue This Year | $170.51 | $27.11 |
| Revenue Next Year | $205.56 | $104.97 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 62.65 | N/A |
| 52 Week Low | $0.65 | $0.13 |
| 52 Week High | $2.02 | $9.54 |
Technical Indicators
Market Signals| Indicator | LUCY | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 41.85 | 17.54 |
| Support Level | $0.80 | $0.22 |
| Resistance Level | $0.97 | $2.50 |
| Average True Range (ATR) | 0.04 | 0.16 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 7.48 | 10.45 |
Price Performance
Historical ComparisonAbout LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.